Literature DB >> 31012941

The States as Important Laboratories for Federal Prescription Drug Cost-Containment Efforts.

Jane C Horvath1, Gerard F Anderson2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31012941     DOI： 10.1001/jama.2019.2189

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Analysis of State-Level Drug Pricing Transparency Laws in the United States.

Authors:  Martha S Ryan; Neeraj Sood
Journal:  JAMA Netw Open       Date:  2019-09-04

2.  Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.

Authors:  Kai Yeung; Stacie B Dusetzina; Anirban Basu
Journal:  JAMA Netw Open       Date:  2021-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.